All News Top News May 26, 2019 Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company Learn More Share Top News May 10, 2019 Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States Learn More Share Top News May 9, 2019 Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States Learn More Share Top News May 3, 2019 Teva to Present New Long-Term Data on Efficacy and Safety of Fremanezumab at 2019 American Academy of Neurology Annual Meeting Learn More Share Top News May 2, 2019 Teva Reports First Quarter 2019 Financial Results Learn More Share
Top News May 26, 2019 Company Statement: Teva Reaches Agreement with State of Oklahoma to Resolve State’s Claims Against the Company Learn More
Top News May 10, 2019 Teva Announces the Launch of a Generic Version of Delzicol® (mesalamine) Delayed-Release Capsules in the United States Learn More
Top News May 9, 2019 Teva Announces Launch of a Generic Version of Tarceva® (erlotinib) Tablets in the United States Learn More
Top News May 3, 2019 Teva to Present New Long-Term Data on Efficacy and Safety of Fremanezumab at 2019 American Academy of Neurology Annual Meeting Learn More